Provided by Tiger Trade Technology Pte. Ltd.

Silence Therapeutics Plc

13.29
+0.02000.15%
Volume:723.69K
Turnover:9.67M
Market Cap:800.19M
PE:-10.47
High:13.59
Open:13.37
Low:13.05
Close:13.27
52wk High:17.58
52wk Low:4.19
Shares:60.21M
Float Shares:38.85M
Volume Ratio:0.75
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2693
EPS(LYR):-1.8761
ROE:-90.41%
ROA:-29.65%
PB:20.80
PE(LYR):-7.08

Loading ...

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Apr 06

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Mar 30

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Mar 27

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Mar 26

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Mar 24

European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live
·
Mar 23

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Higher Monday

MT Newswires Live
·
Mar 16

Prospective, Multi-center Study Published in Future Oncology Demonstrates DecisionDx®-Melanoma’s i31-SLNB Result Outperforms Staging Criteria in Identifying Patients with Cutaneous Melanoma Below the 5% NCCN Threshold for Forgoing SLNB

GlobeNewswire
·
Mar 13

Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), Silence Therapeutics (SLN)

TIPRANKS
·
Mar 13

Chardan Capital Keeps Their Buy Rating on Silence Therapeutics (SLN)

TIPRANKS
·
Mar 09

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Mar 09

DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk

GlobeNewswire
·
Mar 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 06

Goldman Sachs Reaffirms Their Sell Rating on Silence Therapeutics (SLN)

TIPRANKS
·
Mar 06